Topic

New York

A collection of 516 issues

Get Defitelio (Defibrotide) Covered by Aetna CVS Health in New York: Prior Authorization Guide & Appeals Process

Answer Box: Getting Defitelio Covered by Aetna CVS Health in New York Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) with organ dysfunction post-transplant. Key requirements: documented VOD/SOS diagnosis using Baltimore or Cairo criteria, evidence of renal or pulmonary

How to Get Mavenclad (Cladribine Tablets) Covered by Cigna in New York: A Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Cigna in New York Cigna requires prior authorization for Mavenclad (cladribine tablets) with strict step therapy requirements. You must document failure/intolerance of two other MS therapies OR one high-efficacy agent (Ocrevus, Tysabri, Kesimpta, Lemtrada, or Briumvi). Your neurologist submits the PA through Cigna&

Do You Qualify for Xywav Coverage by UnitedHealthcare in New York? Decision Tree & Appeals Guide

Quick Answer: Getting Xywav Covered by UnitedHealthcare in New York Eligibility: You likely qualify if you have narcolepsy (type 1 or 2) or idiopathic hypersomnia with documented sleep study results, are enrolled in the REMS program, and have tried required step therapy medications. Fastest path: Submit prior authorization through OptumRx

How to Get Isturisa (Osilodrostat) Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Isturisa Covered by Cigna in New York Fastest path to approval: Submit prior authorization through CoverMyMeds with endocrinologist consultation, confirmed Cushing's syndrome diagnosis, and surgical history documentation. If denied, you have 180 days for internal appeal, then 4 months for New York DFS external review—

How to Get Carbaglu (Carglumic Acid) Covered by Cigna in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Carbaglu Covered by Cigna in New York Cigna requires prior authorization for Carbaglu (carglumic acid) for NAGS deficiency and organic acidemias. To get coverage: (1) Have your metabolic specialist submit a PA request through Cigna's provider portal with genetic confirmation, baseline ammonia levels, and protein-restricted

How to Get Spinraza (nusinersen) Covered by Aetna CVS Health in New York: Complete Guide to Prior Authorization, Appeals, and State External Review

Answer Box: Getting Spinraza (nusinersen) Covered by Aetna CVS Health in New York Spinraza requires prior authorization from Aetna CVS Health in New York but does not require step therapy. To get approved: (1) Ensure genetic confirmation of 5q SMA and baseline motor function testing by a neurologist, (2) Submit

How Long Does It Take to Get Krystexxa (Pegloticase) Approved by Aetna (CVS Health) in New York? Timeline & Milestones

Answer Box: Getting Krystexxa Approved by Aetna in New York Standard timeline: 15-30 days for initial prior authorization; 72 hours for expedited appeals through New York DFS if urgent. Key requirements: G6PD deficiency screening (negative), failed conventional therapy documentation, rheumatologist prescription, and methotrexate co-therapy unless contraindicated. First step: Contact your

How to Get Idelvion (Albutrepenonacog Alfa) Covered by UnitedHealthcare in New York: Prior Authorization, Appeals, and Coding Guide

Answer Box: Getting Idelvion Covered by UnitedHealthcare in New York Yes, UnitedHealthcare covers Idelvion (albutrepenonacog alfa) in New York, but requires prior authorization and often step therapy. The fastest path: Have your hematologist submit a PA request through the UnitedHealthcare Provider Portal using ICD-10 code D67 and HCPCS code J7202,

How to Get Humira (adalimumab) Covered by Cigna in New York: 2025 Guide to Forms, Appeals, and Biosimilar Changes

Answer Box: Getting Humira Covered by Cigna in New York Cigna removed brand Humira from most 2025 formularies, requiring step therapy through preferred biosimilars first. Three steps to coverage: (1) Try Cigna-preferred adalimumab biosimilars via Accredo specialty pharmacy at $0 copay, (2) If biosimilars fail, request formulary exception with detailed

If Kesimpta Isn't Approved by Blue Cross Blue Shield in New York: Formulary Alternatives & Exception Paths

Answer Box: Kesimpta Alternatives with BCBS New York If Blue Cross Blue Shield denies Kesimpta (ofatumumab) in New York, formulary alternatives include Ocrevus, Tysabri, Tecfidera, and interferon-based DMTs. Most BCBS NY plans require step therapy with oral or injectable DMTs before approving high-cost biologics. Your fastest path: request a formulary